Colour | Indication | Duration |
---|---|---|
Red = high priority | Chronic inflammatory demyelinating polyneuropathy | Short term (blue as long term) |
Guillain-Barré syndrome | Short term | |
Immune thrombocytopenic purpura | Short term | |
Kawasaki disease | Short term | |
Primary immune deficiency | Long term | |
Specific antibody deficiency | Long term | |
Toxic epidermal necrolysis/Stevens Johnson syndrome | Short term | |
Blue = medium priority | Immunobullous disease | Long term |
Inflammatory myopathies | Long term | |
Multifocal motor neuropathy | Long term | |
Myasthenia gravis | Short term | |
Secondary antibody deficiency | Long term | |
Staphylococcal/Streptococcal toxic shock syndrome | Short term | |
Grey = low priority | Autoimmune encephalitis | |
Pyoderma gangrenosum | ||
Systemic vasculitides |
Adapted from the Department of Health Demand Management Plan for Immunoglobulin Use